|
|
Volumn 34, Issue 3, 2002, Pages 942-
|
|
Tacrolimus, daclizumab, sirolimus, and budesonide after small bowel transplantation in order to reduce nephrotoxicity
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B;
BUDESONIDE;
CALCINEURIN INHIBITOR;
GANCICLOVIR;
IMMUNOGLOBULIN G;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PREDNISOLONE;
RAPAMYCIN;
TACROLIMUS;
ASCENDING COLON;
CANDIDIASIS;
CASE REPORT;
CONFERENCE PAPER;
CREATININE CLEARANCE;
CYTOMEGALOVIRUS INFECTION;
DESCENDING COLON;
DRUG BLOOD LEVEL;
EPSTEIN BARR VIRUS;
GANGRENE;
GRAFT REJECTION;
HLA MATCHING;
HUMAN;
HUMAN TISSUE;
ILEOSTOMY;
ILEUM;
IMMUNOGENICITY;
IMMUNOPROPHYLAXIS;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE TRANSPLANTATION;
JEJUNUM;
KIDNEY FUNCTION;
LYMPHOVENOUS ANASTOMOSIS;
NEPHROTOXICITY;
OPPORTUNISTIC INFECTION;
ORGAN DONOR;
PRIORITY JOURNAL;
SMALL INTESTINE DISEASE;
ANASTOMOSIS, SURGICAL;
ANTIBODIES, MONOCLONAL;
BUDESONIDE;
DRUG THERAPY, COMBINATION;
HUMANS;
ILEUM;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINE, SMALL;
JEJUNUM;
KIDNEY;
SIROLIMUS;
TACROLIMUS;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
|
EID: 0036258762
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02682-9 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (1)
|
